The Motley Fool Unveils Top Biotech Stock Picks for 2026 Exicure Q2 2022 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development Arvind Sanger Maintains Cautiously Optimistic View on Indian Markets Focuses on Earnings Revival